Ironwood Pharmaceuticals, Inc. (IRWD)
3.82
-0.05
(-1.29%)
USD |
NASDAQ |
Oct 09, 16:00
3.81
-0.01
(-0.26%)
After-Hours: 20:00
Ironwood Pharmaceuticals Free Cash Flow (Quarterly) : 58.28M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.28M |
| March 31, 2026 | 5.121M |
| December 31, 2025 | 74.58M |
| September 30, 2025 | 47.58M |
| June 30, 2025 | -15.07M |
| March 31, 2025 | 19.92M |
| December 31, 2024 | 15.21M |
| September 30, 2024 | 9.869M |
| June 30, 2024 | 33.41M |
| March 31, 2024 | 44.92M |
| December 31, 2023 | 35.62M |
| September 30, 2023 | 32.41M |
| June 30, 2023 | 34.96M |
| March 31, 2023 | 80.16M |
| December 31, 2022 | 79.21M |
| September 30, 2022 | 69.03M |
| June 30, 2022 | 61.28M |
| March 31, 2022 | 64.12M |
| December 31, 2021 | 64.44M |
| September 30, 2021 | 74.93M |
| June 30, 2021 | 48.57M |
| March 31, 2021 | 73.69M |
| December 31, 2020 | 51.48M |
| September 30, 2020 | 53.63M |
| June 30, 2020 | 19.71M |
| Date | Value |
|---|---|
| March 31, 2020 | 42.16M |
| December 31, 2019 | 24.91M |
| September 30, 2019 | 31.69M |
| June 30, 2019 | -9.237M |
| March 31, 2019 | -42.38M |
| December 31, 2018 | 9.019M |
| September 30, 2018 | -25.23M |
| June 30, 2018 | -22.63M |
| March 31, 2018 | -32.40M |
| December 31, 2017 | -9.026M |
| September 30, 2017 | -32.70M |
| June 30, 2017 | -33.16M |
| March 31, 2017 | -28.88M |
| December 31, 2016 | -120.13M |
| September 30, 2016 | -1.53M |
| June 30, 2016 | -7.378M |
| March 31, 2016 | -0.847M |
| December 31, 2015 | -19.55M |
| September 30, 2015 | -26.65M |
| June 30, 2015 | -26.41M |
| March 31, 2015 | -37.77M |
| December 31, 2014 | -23.82M |
| September 30, 2014 | -39.16M |
| June 30, 2014 | -36.94M |
| March 31, 2014 | -59.19M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| AbbVie, Inc. | 3.114B |
| Xencor, Inc. | -56.20M |
| Viking Therapeutics, Inc. | -125.17M |
| IDEAYA Biosciences, Inc. | -89.08M |
| BioMarin Pharmaceutical, Inc. | 133.86M |